The U.K.’s biggest pharmaceutical firm has agreed to take over the Seattle-based company, which is developing a potential vaccine for two common respiratory diseases
The partnership will focus on the collection, transportation, breaking down and processing of end-of-life lithium-ion EV batteries from the midwest and eastern U.S.
The plan makes EVs ineligible for tax credits if they use more than a trace amount of materials from China or other nations designated as a “foreign entity of concern."
The Japanese carmaker will receive gearboxes and engines for 12 of its plants, as well as half a million parts annually, the companies said December 6.